Culture Biosciences, a leader in cloud-based biomanufacturing, has introduced Stratyx™ 250, the first mobile, cloud-integrated bioreactor, designed to give biotech companies unprecedented flexibility, automation, and remote process control. This innovative solution helps streamline cell culture process development, significantly improving speed, scalability, and efficiency.
As high-throughput experimental methods generate massive volumes of process data, biotech companies often face challenges in extracting actionable insights. Process development frequently requires subject matter experts to design and execute experiments, and a shortage of these specialists can slow innovation and extend development timelines.
Stratyx™ 250: A Smarter, More Efficient Bioprocessing Solution
Stratyx™ 250 directly addresses these challenges by integrating automated, cloud-based process control with intelligent data analytics via Culture Console. Backed by insights from tens of thousands of experiments conducted through Nexxys™—Culture Biosciences‘ robust service model—this cutting-edge system empowers biotech teams to optimize bioprocesses in-house faster, more accurately, and with greater accessibility than ever before.
Key performance benefits include:
- 16% lower total cost per run compared to traditional benchtop bioreactors
- 25% faster development timelines, accelerating process optimization
- 30% improved scale-up success, ensuring better transfer to production
- Real-time process monitoring, enabling remote tracking and adjustments via the Culture Console software
“The biotech and biopharmaceutical market segments are experiencing a major shift toward cloud-powered, modular bioprocessing, and these companies need hardware and software that can keep up,” said Chris Williams, CEO of Culture Biosciences. “With a five-month ROI timeline and a plug-and-play scalable architecture, our platform offers a cost-effective, flexible alternative to traditional bioreactors—helping companies accelerate development and reduce costs without compromising on quality.”
Also Read: NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business
Enhancing Process Development with Cytiva Xcellerex™ Compatibility
Stratyx™ 250 is also designed for compatibility with Cytiva’s 250mL consumable, which features a scaled-down version of the Xcellerex™ X-Platform technology. This includes a specialized sparger and impeller, allowing bioprocessing teams to replicate large-scale reactor conditions in a compact, efficient system. This capability improves process development workflows and speeds up bioprocess optimization, making it an essential tool for both startups and established biopharmaceutical companies.
What is Cloud-Based Bioprocessing?
Cloud-based bioprocessing integrates physical bioreactors with remote data monitoring, automation, and AI-driven optimization, enabling biopharma teams to manage experiments with greater efficiency and precision.
Using Culture Console, researchers can:
- Remotely track and adjust bioreactor parameters in real time, eliminating the need for constant on-site supervision
- Automatically collect and analyze process data, reducing errors and improving reproducibility
- Optimize cell culture conditions and enhance yield, driving more efficient bioprocessing
Addressing the Need for Scalable, Flexible Bioprocessing
Many biotech startups lack in-house lab facilities, and traditional infrastructure can limit flexibility in process development. Stratyx™ 250 eliminates these barriers by offering:
- Cart-based mobility – Easily relocate within labs without infrastructure integration
- Cloud-based automation – Monitor and optimize experiments remotely via Culture Console
- Single-use bioreactor technology – Reduces downtime by eliminating cleaning requirements
- Automated consumable tracking – Simplifies workflows and improves operational efficiency
By incorporating AI and machine-learning workflows, Stratyx™ 250’s integrated Culture Console platform brings a new level of data-driven precision to bioprocessing—helping biotech teams scale their processes faster, with greater reliability and efficiency.